Search
 

 

Pulmotax


New Data Indicate Effectiveness of Clarient’s Pulmotax™ Test for Lung Cancer.

See study, titled “TLE3 expression is predictive of response to chemotherapy in NSCLC,” included 368 carcinoma samples collected from University Hospital, Zurich, Switzerland.

 
Print  
  Contact Us   |    Trademarks   |   Privacy Policy  |  Terms of Use  |  HIPAA  |  Regulatory & Licensing
Copyright 2011 Clarient, Inc. All Rights Reserved.